2 growing ASX dividend shares named as buys

These dividends looks set to grow strongly over the coming years…
The post 2 growing ASX dividend shares named as buys appeared first on The Motley Fool Australia. –

If you’re interested in adding some growing dividend shares to your portfolio, then you might want to look at the ones listed below.

Both have long runways for growth and are sharing their profits with shareholders each year. Here’s what you need to know about them:

Carsales.Com Ltd (ASX: CAR)

The first dividend share to look at is this auto listings company. It could be a dividend share to consider due to its dominant auto listings business in the ANZ market and its growing international operations.

The latter will soon be bolstered by the addition of Trader Interactive. Carsales recently announced an agreement to acquire the US based digital marketing solutions and services provider to the commercial truck, recreational vehicle, powersports, and equipment industries.

Morgan Stanley is positive on the company and is expecting it to grow its dividend at a solid rate in the coming years. It is forecasting dividends of 62 cents per share in FY 2021 and then 71.6 cents per share in FY 2022. This represents fully franked dividend yields of 3.2% and 3.7%, respectively.

The broker currently has an outperform rating and $23.00 price target on its shares. This compares to the latest Carsales share price of $19.42.

Integral Diagnostics Ltd (ASX: IDX)

Another ASX dividend share to look at is Integral Diagnostics. It is a medical imaging service provider that operates from a total of 72 radiology clinics across the country.

Integral Diagnostics has been a solid performer in FY 2021 thanks to strong demand for its services. For example, during the first half it reported a 29.5% increase in revenue to $170.7 million and a sizeable 61.1% jump in net profit after tax to $23.2 million.

And while its shares don’t provide the biggest yield you’ll find on the market, it will improve over the coming years. Goldman Sachs is forecasting dividends per share of 11 cents in FY 2021, 14 cents in FY 2022, and 15 cents in FY 2023. Based on the latest Integral Diagnostics share price of $4.99, this will mean fully franked yields of 2.2%, 2.8%, and 3%, respectively.

The broker has a buy rating and $5.50 price target on its shares. Goldman believes it is a well-run business in an attractive industry, with a relatively secure volume profile of mid/high single digit growth. It also notes that it has a clear path for further growth through brownfield and M&A activities.

The post 2 growing ASX dividend shares named as buys appeared first on The Motley Fool Australia.

These Dividend Stocks Could Be Your Next Cash Kings (FREE REPORT)

Motley Fool Australia’s Dividend experts recently released a brand-new FREE report revealing 3 dividend stocks with JUICY franked dividends that could keep paying you meaty dividends for years to come.

Our team of investors think these 3 dividend stocks should be a ‘must consider’ for any savvy dividend investor. But more importantly, could potentially make Australian investors a heap of passive income.

Don’t miss out! Simply click the link below to grab your free copy and discover these 3 high conviction stocks now.

Returns As of 15th February 2021

More reading

5 things to watch on the ASX 200 on Thursday

Why the Carsales (ASX:CAR) share price will be in the spotlight today
5 things to watch on the ASX 200 on Tuesday

2 highly rated ASX dividend shares with attractive yields

When the music stops… the investment bankers stop getting paid!

James Mickleboro does not own any shares mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Integral Diagnostics Ltd and Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!